4-chloro-11β-[4-[2-(dimethylamino)ethoxy]phenyl]-estra-1,3,5(10)-triene-3,17beta-diol | 214140-51-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 4-chloro-11β-[4-[2-(dimethylamino)ethoxy]phenyl]-estra-1,3,5(10)-triene-3,17beta-diol
• 英文别名: (11beta,17beta)-4-Chloro-11-{4-[2-(dimethylamino)ethoxy]phenyl}estra-1,3,5(10)-triene-3,17-diol；(8S,9R,11S,13S,14S,17S)-4-chloro-11-[4-[2-(dimethylamino)ethoxy]phenyl]-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
• CAS: 214140-51-9
• 化学式: C₂₈H₃₆ClNO₃
• 分子量: 470.052
• InChiKey: DVBSGAHYOBEMBU-QVVDWPINSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  33
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  52.9
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• New 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
  申请人：Hoechst Marion Roussel

  公开号：US20010005756A1

  公开（公告）日：2001-06-28

  A subject of the invention is the compounds of formula (I): 1 in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R 1 , R 2 , R 3 , R 4 , Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.

  本发明的主题是公式（I）的化合物：1其中X是卤素原子，D代表可选择取代的五角形或六角形环的余数，可选地带有不饱和度，R1，R2，R3，R4，Y和n如描述中所定义，它们的制备过程和中间体，它们作为药物的用途以及包含它们的组合物。
• 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
  申请人：——

  公开号：US20020040135A1

  公开（公告）日：2002-04-04

  A subject of the invention is the compounds of formula (I): 1 in which X is a halogen atom, D represents the remainder of an optionally substituted pentagonal or hexagonal ring and optionally carrying an unsaturation, R 1 , R 2 , R 3 , R 4 , Y and n are as defined in the description, their preparation process and intermediates, their use as medicaments and the compositions containing them.

  本发明的主题是公式（I）的化合物：1其中X是卤素原子，D代表一个可选择取代的五边形或六边形环的余数，可选择携带不饱和度，R1，R2，R3，R4，Y和n如描述中所定义，它们的制备过程和中间体，它们作为药物的用途以及包含它们的组合物。
• NOUVEAUX STEROIDES 4-HALOGENES, LEUR PROCEDE ET INTERMEDIAIRES DE PREPARATION, LEUR APPLICATION COMME MEDICAMENTS ET LES COMPOSITIONS PHARMACEUTIQUES LES RENFERMANT
  申请人：Aventis Pharma S.A.

  公开号：EP0973793B1

  公开（公告）日：2002-07-10
• US6239121B1
  申请人：——

  公开号：US6239121B1

  公开（公告）日：2001-05-29
• US6399766B2
  申请人：——

  公开号：US6399766B2

  公开（公告）日：2002-06-04